Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

Sponsor: New York State Psychiatric Institute
Recruitment Status: Not yet recruiting
First Posted: December 7, 2020

~

Psychedelic‐assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports (Stewart et al.)

Published: Dec 5, 2020
Pharmacology Research & Perspectives

~

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma (Kolaczynska et al.)

Published: Dec 7, 2020
Journal of Chromatography B

~

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health (Gandy et al.)

Published: Dec 6, 2020
Health Psychology Open